Terazosin Hydrochloride Capsule
Product Images NDC 71610-698

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 71610-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0698 30)

Label for Terazosin Hydrochloride 2 mg capsules by Aphena Pharma Solutions - Tennessee, LLC. The label indicates the product contains 30 capsules and includes storage instructions. It shows the NDC 71610-0698-30 and manufacturer details. The label specifies the route as oral and highlights to keep out of reach of children.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

Chemical structure of Terazosin Hydrochloride showing its molecular arrangement including rings, functional groups, and hydrochloride component as part of the compound.*

FDA Label Image

Figure1 (Figure1)

This figure displays two line charts comparing Terazosin Hydrochloride to placebo over a three-month period. The left chart shows mean change in total symptom score from baseline with Terazosin and placebo groups, indicating a greater decrease for Terazosin. The right chart illustrates mean increase in peak flow rate in mL/sec, showing higher increases for Terazosin compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the mean change from baseline over 30 months. The x-axis represents time in months from 0 to 30, and the y-axis shows the mean change from baseline ranging from 0 to -7. Data points are plotted with circles and connected by lines, with several points marked by asterisks to indicate statistical significance.*

FDA Label Image

Figure3 (Figure3)

A line graph showing mean change from baseline in mL/sec over 30 months, with data points at each month and error bars representing variability. Statistically significant changes are marked with asterisks at multiple time points, indicating trends in the measured parameter over the study duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.